Pharmaceutical Industry Today

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market to Reach $266.81 million by 2031 | CAGR 4.8%

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is gaining momentum as awareness of gut health and digestive disorders continues to rise worldwide. Increasing recognition of SIBO as a commonly misdiagnosed condition, along with the growing demand for non-invasive breath tests and microbiome-based diagnostics, is driving market expansion.
Published 30 April 2026

According To The Insight Partners, Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market size is projected to reach US$ 266.81 million by 2031 from US$ 155.60 million in 2023. The market is expected to register a CAGR of 4.8% during 2023–2031. The global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is gaining significant traction as awareness of gut health continues to expand worldwide. With increasing recognition of digestive disorders and the rising burden of irritable bowel syndrome (IBS)-like symptoms, healthcare providers and diagnostic companies are prioritizing early detection and accurate testing solutions. This press release highlights key trends, market dynamics, regional outlook, and the future forecast of the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market through 2031.

Market Overview

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is evolving rapidly as healthcare systems increasingly focus on gastrointestinal disorders. SIBO occurs when bacteria grow excessively in the small intestine, leading to symptoms such as bloating, abdominal discomfort, and irregular bowel movements. Growing awareness among clinicians and patients is driving demand for reliable testing solutions.

Get a Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00020544

Recent health news highlights the rising recognition of SIBO as a frequently misdiagnosed condition often confused with IBS. Experts suggest that many patients suffering from chronic digestive symptoms may actually have SIBO, underscoring the importance of improved diagnostic awareness and early testing.

Additionally, the growing popularity of breath tests and clinical advancements in gut microbiome research are reshaping the competitive landscape.

Key Drivers Shaping the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is driven by a combination of clinical demand, technological progress, and patient awareness.

Rising gastrointestinal disease burden

Digestive disorders are becoming increasingly common worldwide. Persistent symptoms such as bloating and abdominal pain are pushing healthcare providers to adopt advanced diagnostic tools.

Growing awareness of misdiagnosis

Medical experts emphasize that SIBO is frequently mistaken for IBS, creating a strong need for accurate diagnostic pathways and improved testing solutions.

Shift toward non-invasive diagnostics

Breath testing is widely used due to its convenience and cost-effectiveness. The test measures hydrogen or methane in breath samples to detect bacterial fermentation.

Advancements in microbiome research

The expansion of gut microbiome research is enabling new biomarker discovery and improved diagnostic accuracy.

Growing interest in at-home testing solutions

The rise of consumer health awareness has fueled demand for home-based diagnostic kits, although experts emphasize the need for clinical validation.

Updated Market News and Industry Developments

Recent news highlights several developments shaping the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market:

  • Experts warn that SIBO awareness is rising globally, but the condition may still be underdiagnosed in many patients.
  • Gastroenterologists emphasize the importance of proper clinical testing to avoid false positives and misdiagnosis.
  • Growing research into microbiome testing and biomarker-based diagnostics is opening new opportunities for innovation.

These developments demonstrate the increasing importance of diagnostic accuracy and the growing role of innovation in this market.

Global Market Analysis

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is expanding globally due to rising digestive health awareness and increased adoption of advanced testing methods.

North America remains a key market driven by strong healthcare infrastructure, advanced diagnostic laboratories, and high awareness of gastrointestinal disorders.

Europe follows closely, supported by growing research initiatives and expanding clinical adoption of breath testing.

Asia-Pacific is emerging as a high-growth region due to increasing healthcare spending, expanding medical infrastructure, and rising awareness of gut health.

Latin America and the Middle East & Africa are witnessing gradual adoption, supported by improving healthcare access and diagnostic capabilities.

Regional Insights

North America

High awareness of gut disorders, strong reimbursement systems, and advanced clinical research make this region a leader in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market.

Europe

Growing healthcare investments and research collaborations are supporting market growth.

Asia-Pacific

Rapid urbanization, changing dietary habits, and expanding healthcare access are creating significant opportunities.

Middle East & Africa and Latin America

These regions are witnessing gradual adoption of SIBO diagnostics driven by improving healthcare infrastructure.

Market Trends Transforming the Industry

Several emerging trends are shaping the future of the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market:

  • Increased adoption of non-invasive breath testing
  • Rising demand for personalized medicine and microbiome analysis
  • Expansion of home-based diagnostic testing
  • Integration of artificial intelligence in diagnostic tools
  • Growing focus on preventive healthcare

Market Forecast Highlights to 2031

Market Size Outlook

  • Continued expansion driven by rising digestive health awareness
  • Increasing demand for early and accurate diagnostic testing

Market Share Insights

  • Breath testing expected to remain the dominant diagnostic approach
  • Growing contribution from microbiome-based testing technologies

Market Trends

  • Rapid adoption of personalized and precision diagnostics
  • Increasing partnerships between diagnostic labs and healthcare providers
  • Rising patient preference for non-invasive testing methods

Market Analysis

  • Strong pipeline of research in microbiome and biomarker-based diagnostics
  • Increasing investments in healthcare infrastructure globally

Market Forecast

  • Consistent growth expected through 2031
  • Asia-Pacific projected to show fastest regional expansion
  • Technological innovation expected to reshape diagnostic accuracy

Competitive Landscape

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market features a mix of global diagnostic companies, specialty laboratories, and emerging startups focused on gut health innovation. Strategic collaborations, product launches, and research partnerships remain key strategies to strengthen market presence.

Get Premium Research Report Market Size and Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00020544

Future Outlook

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is poised for strong growth through 2031 as awareness of gut health rises globally. Advancements in non-invasive testing, microbiome research, and personalized diagnostics are transforming the industry. With increasing recognition of SIBO as a commonly misdiagnosed condition, the demand for accurate and accessible diagnostic solutions will continue to grow worldwide.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish




Other Industry News

Ready to start publishing

Sign Up today!